{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-065497","form_type":"8-K","ticker":"JAZZ","cik":"0001232524","company_name":"Jazz Pharmaceuticals plc","filed_at":"2026-10-09T13:02:20+00:00","discovered_at":"2026-10-09T13:03:00.185922+00:00","generated_at":"2026-10-12T15:16:11.244451+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Jazz Pharmaceuticals CCO Samantha Pearce to retire by June 30, 2027; successor search launched","bullets":["Executive Vice President and Chief Commercial Officer Samantha Pearce notified Jazz on Oct 6, 2026 of her intent to retire.","Retirement takes effect upon the earlier of the selection and appointment of her successor or June 30, 2027.","Jazz plans a formal search for a new Chief Commercial Officer, considering both internal and external candidates.","No successor has been named; Pearce continues as CCO during the transition."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-065497","json":"https://secwatch.observer/filing/0001628280-26-065497.json","markdown":"https://secwatch.observer/filing/0001628280-26-065497.md","text":"https://secwatch.observer/filing/0001628280-26-065497.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1232524/000162828026065497/0001628280-26-065497-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1232524/000162828026065497/jazz-20261006.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-12T15:16:11.244451+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b0d7819266","claim":"Samantha Pearce departed as Executive Vice President, Chief Commercial Officer at Jazz Pharmaceuticals plc.","evidence_excerpt":"On October 6, 2026, Samantha Pearce, Executive Vice President, Chief Commercial Officer of Jazz Pharmaceuticals plc (the “Company” ), notified the Company of her intent to retire from her role as Chief Commercial Officer upon the earlier of the selection and appointment of her successor or by June 30, 2027.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1232524/000162828026065497/0001628280-26-065497-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"retire"},{"label":"Role","value":"Executive Vice President, Chief Commercial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}